Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by skiboard09on May 06, 2021 12:24am
143 Views
Post# 33138559

RE:RE:RE:RE:Lack of trading volume allows the share price to drift down

RE:RE:RE:RE:Lack of trading volume allows the share price to drift down

When will investors finally vote Howard out. Like how can they blow time line after timeline. I know it's not in there control all the time. But for this to continually repeat over and over is unacceptable. 

So many items have been over stated on timelines. 


we need a full time ceo with experience. If the science is as good as it is a good ceo can make things happen. 


where is pet deal, Wangbang material news, top 10 pharma, China partnership, non dilutive financing. Which I think will be tied to one of the deals. 


he mentioned R&F is worth way more then what we have seen....well where is the real value?  


anyoen. Bueller 

<< Previous
Bullboard Posts
Next >>